What is West Pharmaceutical Services's D&A?

West Pharmaceutical Services (WST) reported D&A of $45.7M in Q2 2026.

How has West Pharmaceutical Services's D&A changed year-over-year?

West Pharmaceutical Services's D&A increased by 12.0% year-over-year, from $40.8M to $45.7M.

What is the long-term trend for West Pharmaceutical Services's D&A?

Over 4 years (2021 to 2025), West Pharmaceutical Services's D&A has grown at a 9.6% compound annual growth rate (CAGR), from $116.9M to $168.6M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

West Pharmaceutical Services WST D&A

D&A at other companies

Becton, Dickinson and CompanyBDX

$563M-0.7%

AptarGroupATR

$64.31M+17.1%

Halozyme TherapeuticsHALO

$4.22M+57.1%

AVT

AvantorAVTR

$105.6M+2.8%

DowDOW

$664M-8.3%

DuPont de Nemours, Inc.DD

$155M-3.1%

Segments

By segment

See full

Proprietary Products$36.3M+7.7%

West Vantage$9.2M—

Other financials

Income statement

See full

Revenue$872.3M+13.8%

Gross profit$329.2M+20.2%

Operating income$179.1M+16.5%

Net income$154.0M+16.8%

EPS (diluted)$2.15+18.1%

Balance sheet

See full

Cash & equivalents$435.8M-14.5%

Total debt$316.5M+2.7%

Total equity$3.0B+2.1%

Total assets$4.1B+3.1%

Cash flow

See full

Operating cash flow$124.0M-30.0%

CapEx$43.2M-42.6%

Free cash flow$80.8M-20.7%

Valuation

See full

Market cap$23.72B+32.5%

Enterprise value$23.6B+33.4%

P/E42×+5.3×

P/S7.1×+1.1×

Profitability

See full

Gross margin36.8%+1.5pp

Operating margin20.5%+0.8pp

Net margin17%+0.5pp

FCF margin13.1%+1.5pp

Returns & leverage

See full

Return on equity19.1%+1.4pp

Debt / equity0.1×0.0×

Current ratio2.8×0.0×

Where this comes from

Reported directly by West Pharmaceutical Services in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about West Pharmaceutical Services's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is West Pharmaceutical Services's D&A?: West Pharmaceutical Services (WST) reported D&A of $45.7M in Q2 2026.
How has West Pharmaceutical Services's D&A changed year-over-year?: West Pharmaceutical Services's D&A increased by 12.0% year-over-year, from $40.8M to $45.7M.
What is the long-term trend for West Pharmaceutical Services's D&A?: Over 4 years (2021 to 2025), West Pharmaceutical Services's D&A has grown at a 9.6% compound annual growth rate (CAGR), from $116.9M to $168.6M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.